Drug Discovery World

OCTOBER 10, 2022

This article reviews the challenges and solutions required to expand the use of digital biomarkers to meet the growing demand for more effective drugs that act on the central nervous system. . Psychiatric and neurological drug development is entering a new realm where stratified approaches are finally being applied successfully.

Development 52

Development Drugs Clinical Trials Clinical Trials 52

WCG Clinical

MAY 15, 2023

Additionally, participants with cognitive limitations may not be able to navigate the eDiary platform, and even people without cognitive issues may struggle with complex assessments. They can help tailor the endpoints, assessments and technology to the needs of the relevant patient population.

Clinical Research 52

Clinical Research Development Trials Research 52

World of DTC Marketing

NOVEMBER 11, 2020

” According to Annual Reviews “in general, we do not have the cognitive capacity, motivation, or time to evaluate all the information that we encounter online. However, motivation is increased when we are to research a topic regarding our own health condition or symptoms.

Marketing 195

Marketing Pharma Companies Sales Drugs 195

Pharmaceutical Technology

DECEMBER 27, 2022

Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions. Urtė Fultinavičiūtė also wrote about the complex factors that prevent the participation of people with cognitive impairments , and how proving consent remains a challenge.

Clinical Trials 306

Clinical Trials Clinical Trials Trials Vaccination 306

pharmaphorum

OCTOBER 14, 2021

NHS Scotland will offer the digital health firm’s Sleepio and Daylight, and the cognitive behavioural therapy they provide, to all adults via their GP or online self-referral greatly expanding their previous availability.

96

96

pharmaphorum

JANUARY 27, 2022

Our book Applied Virtual Reality in Healthcare provides an overview of innovative approaches, best practices, and coherent solutions to common concerns. “For many of the medications, for example, SSRIs, we get greater efficacy when we combine their use with concurrent cognitive behavioural therapy.”

Production 140

Production Behavioural Health Development Clinical Trials 140

pharmaphorum

NOVEMBER 2, 2022

Treating pain has always been complicated because often the most effective solutions come with their own risks. Though it provided a solution, opium also brought with it physical and psychological dependence. The potential for a digital solution. Making breakthroughs.

Development 135

Development Trials Drugs Production 135

XTalks

APRIL 22, 2021

The researchers found that the cognitive impairments were associated with changes in the gut microbiota induced by high sugar levels. Given that the hippocampus regulates a variety of cognitive functions, and that it is still developing into late adolescence, the researchers wanted to learn about its susceptibility to a high-sugar diet.

Development 76

Development Bacteria Research Regulation 76

Trialfacts

OCTOBER 3, 2022

Must have the cognitive and functional capability to operate the controls for the devices and to comply with all directions during the study. You will receive a hearing assessment. You may receive the following assessments: cognition, vision, walking ability. Who Can Participate? Individuals with hearing loss.

Research 40

Research Development Branding Licensing 40

pharmaphorum

JULY 23, 2021

The therapy uses a VR headset to guide people with chronic pain through a series of cognitive behavioural therapy (CBT) exercises that are designed to help them overcome the fear of movement – also known as Kinesiophobia, and then re-engage in an active life.

Clinical Trials 145

Clinical Trials Clinical Trials Trials Development 145

XTalks

DECEMBER 11, 2023

Related: Top 10 Medical Device Companies in 2023: Statistics and Trends 1) Axonics Based in California, Axonics is a renowned global medical technology firm dedicated to the development and commercialization of innovative solutions for adults grappling with bladder and bowel dysfunction.

Production 110

Production Sales In-Vitro Development 110

Drug Discovery World

FEBRUARY 22, 2024

The FDA has approved the supplemental Biologics License Application (sBLA) supporting the traditional approval of LEQEMBI (lecanemab-irmb) injection, for reducing the rate of disease progression and to slow cognitive and functional decline in adults with Alzheimer’s disease (AD).

Drugs 59

Drugs Gene Clinical Trials Clinical Trials 59

The Pharma Data

JULY 23, 2021

The company’s contributions to AAIC will include several presentations highlighting data on ADUHELM (aducanumab-avwa) injection 100 mg/mL solution, which was recently granted accelerated approval by the U.S. About ADUHELM (aducanumab-avwa) injection 100 mg/mL solution ADUHELM is indicated for the treatment of Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Development 52

XTalks

JUNE 23, 2023

The aim of this research is to find solutions for preventing clinician burnout, enhancing patient care and improving workflows in medical practices. The funded studies for 2023 will focus on examining the relationships between EHR use and physician cognitive load, as well as the impact of EHR use on team structures and care team processes.

Research 96

Research Allergies Medicine Pharmacy 96

XTalks

AUGUST 19, 2021

Xywav (calcium, magnesium, potassium and sodium oxybates) is an oral solution that is used to treat cataplexy (sudden onset of muscle weakness or paralysis) or excessive daytime sleepiness (EDS) in patients with narcolepsy. This, despite the drug having strict regulations and safety concerns. GHB has a long and interesting history.

FDA Approval 64

FDA Approval Drugs Regulation Sales 64

pharmaphorum

APRIL 6, 2022

Across the healthcare industry, the challenge of patient adherence is often discussed and game-based therapeutics could provide a solution to this particular problem – by providing a therapy that treats a patient’s condition whilst also being entertaining. It’s in the game.

Development 110

Development Clinical Development Production Trials 110

XTalks

APRIL 29, 2021

Although various solutions to this issue have been proposed, such as conducting virtual trials and hiring ethnically diverse clinical trial investigators, language ultimately plays a vital role in fostering patient diversity. Materials are then back translated into the source language and reviewed again.

Clinical Trials 95

Clinical Trials Clinical Trials Trials Drugs 95

The Pharma Data

DECEMBER 21, 2020

Now two companies have developed novel solutions with the sensitivity and specificity needed to provide ample warning. Vir Biotechnology and GlaxoSmithKline dosed the first patient in a new sub-trial of a Phase III study assessing the monoclonal antibody VIR-7831 as a potential treatment of hospitalized adults diagnosed with COVID-19.

Vaccination 52

Vaccination Vaccine Trials Allergies 52

Drug Discovery World

DECEMBER 18, 2023

Deepika Khedekar, Clinical Trial Lead at IQVIA, provides an overview of the pros and cons, and suggests a possible solution. Just as digital biomarkers are reshaping cardiovascular research, they are also making strides in the realm of cognitive health.

Clinical Research 59

Clinical Research Research Clinical Trials Clinical Trials 59

ACRP blog

FEBRUARY 15, 2023

The time has come for sponsors and clinical research organizations to accurately assess the costs to individuals tied to their research participation and provide them with just compensation for their service. There are no simple solutions. Yet, this outcome can be greatly improved through thoughtful and intentional engagement.

Clinical Trials 52

Clinical Trials Clinical Trials Clinical Research Trials 52

Drug Discovery World

JANUARY 12, 2023

DDW learnt more about this in an interview with Mark Matson, Senior Solution Specialist for Sensor Cloud at Medidata, focussing on how the use of digital biomarkers in life sciences and how they can help advance our understanding of disease. She hoped that in 2022, this would be utilised.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

The Pharma Data

DECEMBER 9, 2020

The authors performed quantitative computed tomography (CT) to assess volumetric bone mineral density and proton magnetic resonance spectroscopy to measure fat within bones of the lumbar spine at baseline and 12 months. The investigators found that weight loss surgery in adolescents decreased bone strength. ” Press Release. 29 to Dec.

Radiology 52

Radiology Biobanking Genotype Medicine 52

The Pharma Data

JULY 29, 2021

Eisai and Biogen Present Preliminary Assessment of the Clinical Effects of Lecanemab Following 18 Months of Treatment in the Open-Label Extension of the Phase 2 Proof of Concept Study at 2021 Alzheimer’s Association International Conference (AAIC) . United States and virtually from July 26 to 30, 2021 (Presentation No.: The plasma A?42/40

Clinical Trials 52

Clinical Trials Clinical Trials Development Antibody 52

The Pharma Data

AUGUST 3, 2021

At the end of May, Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for BI 425809, a key component of the company’s mental health research program, for the treatment of Cognitive Impairment Associated with Schizophrenia (CIAS).

Development 52

Development Research Contract Manufacturing Sales 52

The Pharma Data

JANUARY 5, 2021

RAD011 is a pivotal-trial ready synthetic cannabidiol oral solution with potential utilization in multiple endocrine and metabolic orphan diseases. s (“Benuvia”) synthetic cannabidiol oral solution (“RAD011”). Acquisition and associated PWS trial costs to be funded from existing operations. In the U.S.,

Manufacturing 52

Manufacturing FDA Approval Trials Development 52

Delveinsight

AUGUST 17, 2021

Food and Drug Administration gave a red flag to FibroGen’s anemia pill roxadustat, for the use in patients suffering from kidney diseases owing to safety concerns that arose after results, which in turn are concluded for the presentation of further clinical studies to assess safety for future medicinal use.

FDA Approval 98

FDA Approval Medicine Vaccination Vaccine 98

pharmaphorum

SEPTEMBER 29, 2021

The 10 startups – all from the US – will now embark on a four-week programme of assessment, training and development to ensure their technologies are ready for widespread deployment in the Amazon Web Services (AWS) cloud. The finalists are: AIVA , a startup that has developed a voice operating system for patient care.

FDA Approval 138

FDA Approval Pharmacy Licensing Licensing 138

The Pharma Data

JANUARY 25, 2021

Cummings is the originator of the Neuropsychiatric Inventory (NPI), a widely used clinical test battery that has been translated in over 75 languages and used around the world to assess and monitor dementia-related symptoms. . – January 26, 2021) – NervGen Pharma Corp. About NervGen.

Clinical Development 40

Clinical Development Containment Development Research 40

XTalks

JANUARY 5, 2021

He says that “prior to COVID-19, only agile early adopters were experimenting, piloting and using certain elements of these solutions. It can also help scientists connect virtually, allowing for real-time feedback and assessments. It has really been a catalyst for driving adoption of decentralized clinical trials.”.

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

XTalks

DECEMBER 22, 2021

Digital solutions in healthcare rely on the technologies that enable them. Similarly, wearable ECG monitors that assess heart rates and rhythms could also offer patients a way to monitor the activity and health of their heart more periodically than an occasional visit to the doctor’s office.

Life Science 98

Life Science RNA Vaccination Vaccine 98

pharmaphorum

JULY 13, 2022

And while pharma companies are working hard to find treatments for these diseases, they have a major problem that must be addressed before that work can be done effectively: the lack of objective, quantitative measurement tools for assessing the progression – or even the presence or absence – of these conditions. It’s laughable, right?

Trials 98

Trials Clinical Trials Clinical Trials Pharma Companies 98

Intouch Solutions

DECEMBER 6, 2021

It directly impacts how we, as a media team, assess potential target audiences and determine which are most relevant to a brand. Sponsorships, partnerships, open innovation — just to name a few ways,” says Alex Kareotes, Director, Media & Innovation, Intouch Solutions. “We It gives us freedom, but with a cognitive cost.

Marketing 52

Marketing Branding Sales Clinical Trials 52

XTalks

DECEMBER 4, 2020

Anemia, cognitive decline and frailty are all important concerns for patients with CKD, especially those on dialysis. Nuanced biomarkers capable of identifying and assessing the extent of damage in CKD are necessary to help manage the disease and delay its progression as well as the onset of comorbid conditions like CVD.

Trials 52

Trials Clinical Trials Clinical Trials Antibody 52

pharmaphorum

DECEMBER 14, 2022

Long-term, the firm aims to focus on therapeutic and preventative technology solutions that address unmet needs in some of the most underserved and vulnerable segments of society: women, children, and the elderly. Our investment provides an opportunity to expand Angelini Ventures’ mental health focus with a digital health solution.”.

Life Science 105

Life Science Development Business Development Genetics 105

The Pharma Data

MAY 13, 2021

Effects of glucose-to-fructose ratios in solutions on subjective satiety, food intake, and satiety hormones in young men. After daily bingeing on a sucrose solution, food deprivation induces anxiety and accumbens dopamine/acetylcholine imbalance. Environ Monit Assess. Risk assessment for the consumers. Am J Clin Nutr.

Insulin 52

Insulin Production Hormones Medicine 52